- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02902549
Real-time Quantitative Optical Perfusion Imaging in Surgery
Real-time Quantitative Optical Perfusion Imaging in Surgery: a Prospective, Observational, In-vivo, Human, Single-center Study
Surgeons are nowadays unable to visualize and quantitatively evaluate microvascularisation in real-time during surgery. Complications due to vascular compromise are a major problem, especially in reconstructive surgery. Poor blood perfusion leads to ischemia and even tissue necrosis. If, however, perfusion and ischemia could be monitored during surgery, then surgeons could change their reconstructive design and the anaesthesiologists could improve perfusion with fluids, inotropes or vasopressors, if necessary. Surgeons therefore need a tool that is able to image in high resolution (microvascularisation), direct, intra-operative, in 3D (to image thrombosis, luminal narrowing or distinct overlaying vessels) and that produces quantitative data to objectify image interpretation.
Optical techniques, based on the interaction of light with tissue, are able to image tissue at high resolution and in real-time. These techniques are FDA-approved and have emerged as powerful diagnostic tools in different departments of medicine, such as ophthalmology for visualizing retina vascularisation and dermatology for skin diagnostics.
In this study, investigators hypothesize that four novel optical technologies: Fluorescence Imaging, Laser Speckle Contrast Imaging, Optical Coherence Tomography and Sidestream Darkfield Microscopy are able to quantitatively image perfusion in real-time during surgery.
Study Overview
Status
Conditions
Detailed Description
Primary objective - Perfusion will be measured with all the techniques focussed on 4 areas; from 'good' to 'decreased' perfusion (biologically)
Fluorescence Imaging (FI): Time to intensity measurements at four sides Laser Speckle Contrast Imaging (LSCI): Perfusion Units Optical Coherence Tomography (OCT): Vessel density & decorrelation time Sidestream Darkfield Microscopy (SDF): Total vessel density, proportion of perfused vessels, perfused vessel density, max flow index, De Backer score, perfusion in mm/sec.
Differences in parameters between the four sites will be statistically be compared.
Secondary objectives
- Relation of parameters to patient outcome in terms of adverse events.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Amsterdam, Netherlands, 1105 AZ
- Academic Medical Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Age ≥ 18 years - Scheduled for reconstructive surgery with free flap reconstruction or laparoscopic transhiatal and 3-stage transthoracic gastric tube surgery.
Exclusion Criteria:
- Allergic to iodide (indocyanine green)
- Hyper-thyroidism
- Breastfeeding
- No informed consent
- Allergic to ephedrine
- Ischaemic heart disease
- Thyrotoxicosis
- Autonomic thyroid adenomas
- Intraoperative hypertension or tachycardia
Study Plan
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Difference in perfusion between the antrum and fundus (GT) or the artery origin and tip (free flap) measured with OCT.
Time Frame: 1 year
|
- Perfusion will be imaged with OCT and measured in total vessel density.
|
1 year
|
|
Difference in perfusion between the antrum and fundus (GT) or the artery origin and tip (free flap) measured with SDF.
Time Frame: 1 year
|
Perfusion will be imaged with SDF and measured in microvascular flow index.
|
1 year
|
|
Difference in perfusion between the antrum and fundus (GT) or the artery origin and tip (free flap) measured with LSCI.
Time Frame: 1 year
|
flux in perfusion units (LSCI)
|
1 year
|
|
Difference in perfusion between the antrum and fundus (GT) or the artery origin and tip (free flap) measured with FI.
Time Frame: 1 year
|
intensity/time (FI)
|
1 year
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number of participants with treatment-related adverse events as assessed by CTCAE v4.0
Time Frame: 1 year
|
1 year
|
|
|
Distance of watershed to fundus (GT) or artery to tip (flap)
Time Frame: 1 year
|
In the FI images the distance between the end of the right gastroepiploic artery and the fundus, and the distance between the artery entry and tip of the flap can be calculated.
|
1 year
|
|
Measurement-time during surgery
Time Frame: 30 minutes
|
time in minutes will be calculated during measurements
|
30 minutes
|
|
Difference in perfusion between the antrum and fundus (GT) or the artery origin and tip (free flap) measured with OCT.
Time Frame: 1 year
|
- Perfusion will be imaged with OCT and measured in decorrelation time.
|
1 year
|
|
Difference in perfusion between the antrum and fundus (GT) or the artery origin and tip (free flap) measured with SDF.
Time Frame: 1 year
|
Perfusion will be imaged with SDF and measured in total vessel density.
|
1 year
|
|
Difference in perfusion between the antrum and fundus (GT) or the artery origin and tip (free flap) measured with SDF.
Time Frame: 1 year
|
Perfusion will be imaged with SDF and measured in perfused vessel density.
|
1 year
|
|
Difference in perfusion between the antrum and fundus (GT) or the artery origin and tip (free flap) measured with SDF.
Time Frame: 1 year
|
Perfusion will be imaged with SDF and measured in proportion of perfused vessels.
|
1 year
|
|
Difference in perfusion between the antrum and fundus (GT) or the artery origin and tip (free flap) measured with SDF.
Time Frame: 1 year
|
Perfusion will be imaged with SDF and measured in De Backer Score.
|
1 year
|
|
Difference in perfusion between the antrum and fundus (GT) or the artery origin and tip (free flap) measured with SDF.
Time Frame: 1 year
|
Perfusion will be imaged with SDF and measured in velocity in mm/sec.
|
1 year
|
Collaborators and Investigators
Collaborators
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- NL52377.018.15
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Complications of Perfusion
-
Technical University of MunichUnknown
-
Shanglei LiuRecruitingPerfusion; ComplicationsUnited States
-
Second Affiliated Hospital, School of Medicine,...RecruitingPerfusion; ComplicationsChina
-
Nihon KohdenCompleted
-
University of LeipzigUnknownFrequency of Cerebral Perfusion Defects After TAVI | Size of Cerebral Perfusion Defects After TAVIGermany
-
Christie Medical Holdings, Inc.TerminatedPerfusion; ComplicationsUnited States
-
Nova Southeastern UniversityCompletedPerfusion; Complications | Fluid Retention TissueUnited States
-
St. Bortolo HospitalUnknownMechanical Ventilation Complication | Perfusion; ComplicationsItaly
-
Inonu UniversityNot yet recruitingPerfusion; Complications | Arterial Catheterization, Peripheral